Cargando…

Analysis of CD4, CD8, CD19, CD56-16, CD64, QuantiFERON biomarkers in exudative lymphocyte-dominant pleural effusion

BACKGROUND: There are two main causes of exudative effusion including malignancy-induced effusion and tuberculosis. Considering that in reactive ejections, such as tuberculosis-induced effusion, the role of B lymphocytes and in the malignant effusion, the role of T lymphocytes are more important, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehraban, Zahra, Pourdowlat, Guitti, Mortaz, Esmaeil, Atefeh, Abedini, Ghaforian, Amin R., MalAmir, Mehrdad Dargahi, Bakhtiari, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041266/ https://www.ncbi.nlm.nih.gov/pubmed/36993098 http://dx.doi.org/10.4103/jfmpc.jfmpc_2296_21

Ejemplares similares

Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023)

CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
por: Wang, Ping-Huai, et al.
Publicado: (2020)

Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
por: Powell, Richard D., et al.
Publicado: (2011)

QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
por: Kim, Soo Han, et al.
Publicado: (2020)

Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis
por: Moon, Hee-Won, et al.
Publicado: (2020)

Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
por: Ahn, Sung Soo, et al.
Publicado: (2021)

QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for detecting latent tuberculosis infection in Thai healthcare workers
por: Rudeeaneksin, Janisara, et al.
Publicado: (2023)

Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection
por: Kim, Ock-Hwa, et al.
Publicado: (2020)

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

Influence of Seasonality and Circulating Cytokines on Serial QuantiFERON Discordances
por: Griffin, Marsha L., et al.
Publicado: (2018)

The Initial QuantiFERON-Lyme Prototype is Unsuitable for European Patients
por: Baarsma, M E, et al.
Publicado: (2021)

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus
por: Gallegos Morales, Elia Noemi, et al.
Publicado: (2017)

Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study
por: Xu, Yuzhen, et al.
Publicado: (2022)

The Frequencies of IFNγ+IL2+TNFα+ PPD-Specific CD4+CD45RO+ T-Cells Correlate with the Magnitude of the QuantiFERON® Gold In-Tube Response in a Prospective Study of Healthy Indian Adolescents
por: Jenum, Synne, et al.
Publicado: (2014)

QuantiFERON-TB gold test versus tuberculin skin test
por: Wiwanitkit, Viroj
Publicado: (2010)

Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children
por: Sali, Michela, et al.
Publicado: (2015)

QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG
por: Carrère-Kremer, Séverine, et al.
Publicado: (2022)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa
por: Ntshiqa, Thobani, et al.
Publicado: (2022)

Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests
por: Whitworth, William C., et al.
Publicado: (2012)

Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test
por: Aabye, Martine G, et al.
Publicado: (2012)

Season Is Associated with Interferon Gamma Measured in QuantiFERON Gold In-Tube Test
por: Agarwal, Saroochi, et al.
Publicado: (2017)

Evaluating an Education Program to Reduce Indeterminate QuantiFERON Gold In-Tube Results
por: Agarwal, Saroochi, et al.
Publicado: (2018)

Performance and variability of QuantiFERON Gold Plus assay associated with phlebotomy type
por: Agarwal, Saroochi, et al.
Publicado: (2018)

Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
por: Hsiao, Chuan-Yu, et al.
Publicado: (2017)

Analysis of cellular and soluble profiles in QuantiFERON nonconverters, converters, and reverters in the Gambia
por: Medawar, Lydia, et al.
Publicado: (2019)

Biomarkers to identify Mycobacterium tuberculosis infection among borderline QuantiFERON results
por: Uzorka, Jonathan W., et al.
Publicado: (2022)

The Pitfalls of Mining for QuantiFERON Gold in Severely Ill Patients With COVID-19
por: Cortes, Melissa P., et al.
Publicado: (2022)

QuantiFERON-TB Gold Plus Performance in Children: A Narrative Review
por: Buonsenso, Danilo, et al.
Publicado: (2023)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised Populations
por: Ariga, Haruyuki, et al.
Publicado: (2011)

Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy
por: Drago, Lorenzo, et al.
Publicado: (2013)

Variability of the QuantiFERON®-TB Gold In-Tube Test Using Automated and Manual Methods
por: Whitworth, William C., et al.
Publicado: (2014)

Diagnostic Utility of QuantiFERON-TB Gold (QFT-G) in Active Pulmonary Tuberculosis
por: Anwar, Ahmed, et al.
Publicado: (2015)

Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing
por: Crossa, Aldo, et al.
Publicado: (2015)

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan
por: Yi, Lina, et al.
Publicado: (2016)

Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients
por: Sood, Siddharth, et al.
Publicado: (2016)

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis
por: Chegou, Novel N., et al.
Publicado: (2018)

1294 Skin Microbiota Contamination Causes False Positive QuantiFERON-TB Results
por: Gaur, Rajiv
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7kf9a2tse56il79679n5slpdf1